display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
metastatic/advanced hepatocellular cancer (mHCC)
lung cancer : non small cell (NSCLC)
MET gene alteration targeted therapy
capmatinib GEOMETRY mono-1

Study type: